Please login to the form below

Not currently logged in
Email:
Password:

Quintiles partners to improve patient care

Quintiles has signed a collaborative agreement to help drive innovation, improve patient care and increase efficiency in early stage clinical research

Quintiles has signed a collaborative agreement with Guy's and St Thomas' NHS Foundation Trust and King's College London to help drive innovation, improve patient care and increase efficiency in early stage clinical research.

As part of the agreement, the biopharmaceutical services company, has commissioned a research facility with 30 beds, for both patients and healthy volunteers involved in research within Guy's Hospital in London. The facility, to be named Quintiles Drug Research Unit, will be completed in early 2010 and will increase Quintiles' capacity to conduct proof-of-concept programmes that help biopharmaceutical companies develop better medicines faster.

Eddie Caffrey, senior vice president, Global Phase I, Quintiles, said: "The biopharmaceutical industry must bring new drugs to market faster and with greater predictability to address declining research and development productivity. The smartest move is to invest in intelligent, early-stage development because, when done well, it has significant impact on speed and cost of the overall development process."

Ron Kerr, chief executive of Guy's and St Thomas' NHS Foundation Trust said: "We want to deliver the best possible care to our patients, and we know that aligning clinical service excellence with translational research has been shown to be one of the most effective ways to do this. We're excited by the potential of this collaboration as it will lead to a smoother and faster clinical trials process, ensuring our patients and local people are among the first to benefit from any new discoveries."

Professor Robert Lechler, vice-principal (health), King's College London and Director of King's Health Partners, said: "King's College London's important partnership with Quintiles and Guy's and St Thomas' NHS Foundation Trust, one of our Academic Health Sciences Centre (AHSC) partners, is exactly the sort of collaboration we expect to see at the heart of King's Health Partners."

Lechler added: "Through this collaboration and the significant investments we have already made to develop first class clinical research facilities, we will create a powerful 'experimental medicine' hub across four floors of the Guy's Hospital Tower, allowing us to harness the expertise of our world class scientists and clinicians to drive new discoveries in medicine and clinical treatment."

27th October 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics